Psychosis prediction in secondary mental health services. A broad, comprehensive approach to the “at risk mental state” syndrome

European Psychiatry

Volumn 40, Issue , 2017, Pages 96-104

  Francesconi, M ^a,b   Minichino, A ^a,b   Carrion R E ^c   Delle Chiaie, R ^a   Bevilacqua, A ^a,d   Parisi, M ^e   Rullo, S ^f   Bersani, F Saverio ^a   Biondi, M ^a   Cadenhead, K ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ZUCKER HILLSIDE HOSPITAL   (United States)

^d Research Center in Neurobiology   (Italy)

^e Villa Armonia Nuova   (Italy)

^f Casa di Cura Villa Letizia   (Italy)

Author keywords

Clinical high risk; Neurocognition; Neurological soft signs; Theory of mind; Ultra high risk

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ALGORITHM; ARTICLE; ASSESSMENT OF HUMANS; AT RISK MENTAL STATE; BEHAVIOR CHANGE; COGNITIVE DEFECT; COMPREHENSIVE ASSESSMENT OF AT RISK MENTAL STATE; CONTROLLED STUDY; DSM-IV; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MENTAL HEALTH SERVICE; NEGATIVE AT RISK MENTAL STATE; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; POSITIVE TO AT RISK MENTAL STATE; PREDICTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PSYCHOLOGICAL WELL-BEING; PSYCHOSIS; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; YOUNG ADULT; ADOLESCENT; MENTAL HEALTH; PROGNOSIS; PSYCHOLOGY; RISK; RISK ASSESSMENT;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MENTAL HEALTH; MENTAL HEALTH SERVICES; PROGNOSIS; PSYCHOTIC DISORDERS; RISK; RISK ASSESSMENT; YOUNG ADULT;

EID: 85006262090     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2016.09.002     Document Type: Article

References (55)

1. [1] Addington, J., Liu, L., Buchy, L., Cadenhead, K.S., Cannon, T.D., Cornblatt, B.A., et al. North American Prodrome Longitudinal Study (NAPLS 2): the prodromal symptoms. J Nerv Ment Dis 203:5 (2015), 328–335.
2. [2] Seidman, L.J., Neuropsychology of the prodrome to psychosis in the NAPLS consortium. Relationship to family history and conversion to psychosis. Arch Gen Psychiatry, 67(6), 2010, 578.
3. [3] Yung, A.R., Yuen, H.P., McGorry, P.D., Phillips, L.J., Kelly, D., Dell'Olio, M., et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 39:11–12 (2004), 964–971.
4. [4] Miller, T.J., McGlashan, T.H., Rosen, J.L., Cadenhead, K., Cannon, T., Ventura, J., et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 29:4 (2003), 703–715.
5. [5] Fusar-Poli, P., Bonoldi, I., Yung, A.R., Borgwardt, S., Kempton, M.J., Valmaggia, L., et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 69:3 (2012), 220–229.
6. [6] Nelson, B., Yuen, H.P., Wood, S.J., Lin, A., Spiliotacopoulos, D., Bruxner, A., et al. Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA Psychiatry 70:8 (2013), 793–802.
7. [7] Simon, A.E., Velthorst, E., Nieman, D.H., Linszen, D., Umbricht, D., de Haan, L., Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophr Res 132:1 (2011), 8–17.
8. [8] Simon, A.E., Borgwardt, S., Riecher-Rössler, A., Velthorst, E., de Haan, L., Fusar-Poli, P., Moving beyond transition outcomes: meta-analysis of remission rates in individuals at high clinical risk for psychosis. Psychiatry Res 209:3 (2013), 266–272.
9. [9] Simon, A.E., Umbricht, D., Lang, U.E., Borgwardt, S., Declining transition rates to psychosis: the role of diagnostic spectra and symptom overlaps in individuals with attenuated psychosis syndrome. Schizophr Res 159:2–3 (2014), 292–298.
10. [10] Cornblatt BA, Carrión RE, Auther A, Mclaughlin D, Olsen RH, John M, et al. Psychosis prevention: a modified clinical high risk perspective from the recognition and prevention (RAP) program. Am J Psychiatry 2015;172(10):986–94.
11. [11] Hanssen, M., Bak, M., Bijl, R., Vollebergh, W., van Os, J., The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol 44:June (Pt 2) (2005), 181–191.
12. [12] Yung, A.R., McGorry, P.D., The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 22:2 (1996), 353–370.
13. [13] Chen, Y., Bidwell, L.C., Norton, D., Trait vs. state markers for schizophrenia: identification and characterization through visual processes. Curr Psychiatry Rev 2:November (4) (2006), 431–438.
14. [14] Simon, A.E., Umbricht, D., High remission rates from an initial ultra-high risk state for psychosis. Schizophr Res 116:2–3 (2010), 168–172.
15. [15] Ziermans, T.B., Schothorst, P.F., Sprong, M., van Engeland, H., Transition and remission in adolescents at ultra-high risk for psychosis. Schizophr Res 126:1–3 (2011), 58–64.
16. [16] Escher, S., Romme, M., Buiks, A., Delespaul, P., van Os, J., Formation of delusional ideation in adolescents hearing voices: a prospective study. Am J Med Genet 114:8 (2002), 913–920.
17. [17] Apter, A., Bleich, A., Tyano, S., Affective and psychotic psychopathology in hospitalized adolescents. J Am Acad Child Adolesc Psychiatry 27:January (1) (1988), 116–120.
18. [18] Ulloa, R.E., Birmaher, B., Axelson, D., Williamson, D.E., Brent, D.A., Ryan, N.D., et al. Psychosis in a pediatric mood and anxiety disorders clinic: phenomenology and correlates. J Am Acad Child Adolesc Psychiatry 39:3 (2000), 337–345.
19. [19] Yee, L., Yee, L., Korner, A.J., McSwiggan, S., Meares, R.A., Stevenson, J., Persistent hallucinosis in borderline personality disorder. Compr Psychiatry 46:2 (2013), 147–154.
20. [20] Rietdijk, J., Klaassen, R., Ising, H., Dragt, S., Nieman, D.H., van de Kamp, J., et al. Detection of people at risk of developing a first psychosis: comparison of two recruitment strategies. Acta Psychiatr Scand 126:1 (2012), 21–30.
21. [21] Brandizzi, M., Valmaggia, L., Byrne, M., Jones, C., Iwegbu, N., Badger, S., et al. Predictors of functional outcome in individuals at high clinical risk for psychosis at six years follow-up. J Psychiatr Res 65:June (2015), 115–123.
22. [22] Lin, A., Wood, S.J., Nelson, B., Brewer, W.J., Spiliotacopoulos, D., Bruxner, A., et al. Neurocognitive predictors of functional outcome two to 13years after identification as ultra-high risk for psychosis. Schizophr Res, 2011.
23. [23] Lee, T.Y., Hong, S.B., Shin, N.Y., Kwon, J.S., Social cognitive functioning in prodromal psychosis: a meta-analysis. Schizophr Res 164:1–3 (2015), 28–34.
24. [24] Tamagni, C., Studerus, E., Gschwandtner, U., Aston, J., Borgwardt, S., Riecher-Rössler, A., Are neurological soft signs pre-existing markers in individuals with an at-risk mental state for psychosis?. Psychiatry Res 210:2 (2013), 427–431.
25. [25] Chan, R.C.K., Xu, T., Heinrichs, R.W., Yu, Y., Wang, Y., Neurological soft signs in schizophrenia: a meta-analysis. Schizophr Bull 36:6 (2010), 1089–1104.
26. [26] Zhang, T., Li, H., Stone, W.S., Woodberry, K.A., Seidman, L.J., Tang, Y., Neuropsychological impairment in prodromal, first-episode, and chronic psychosis: assessing RBANS performance. PLoS ONE, 10(5), 2014, e0125784.
27. [27] Bora, E., Yücel, M., Pantelis, C., Theory of mind impairment: a distinct trait-marker for schizophrenia spectrum disorders and bipolar disorder?. Acta Psychiatr Scand 120:4 (2009), 253–264.
28. [28] Rietdijk, J., Hogerzeil, S.J., van Hemert, A.M., Cuijpers, P., Linszen, D.H., van der Gaag, M., Pathways to psychosis: help-seeking behavior in the prodromal phase. Schizophr Res 132:2–3 (2011), 213–219.
29. [29] Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D.S., Quinn, K., et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 167:7 (2010), 748–751.
30. [30] Ruhrmann, S., Schultze-Lutter, F., Salokangas, R.K.R., Heinimaa, M., Linszen, D., Dingemans, P., et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 67:3 (2010), 241–251.
31. [31] Buchanan, R.W., Heinrichs, D.W., The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 27:3 (1989), 335–350.
32. [32] Kay, S.R., Fiszbein, A., Opler, L.A., The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13:2 (1987), 261–276.
33. [33] Randolph, C., Tierney, M.C., Mohr, E., Chase, T.N., The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol, 2010.
34. [34] Vellante, M., Baron-Cohen, S., Melis, M., Marrone, M., Petretto, D.R., Masala, C., et al. The “Reading the Mind in the Eyes” test: systematic review of psychometric properties and a validation study in Italy. Cogn Neuropsychiatry 18:4 (2013), 326–354.
35. [35] Stone, V.E., Baron-Cohen, S., Knight, R.T., Frontal lobe contributions to theory of mind. J Cogn Neurosci 10:5 (1998), 640–656.
36. [36] Bosco, F.M., Colle, L., De Fazio, S., Bono, A., Ruberti, S., Tirassa, M., Th.o.m.a.s.: an exploratory assessment of Theory of Mind in schizophrenic subjects. Conscious Cogn, 2009.
37. [37] Rosen, A., Hadzi-pavlovic, D., Parker, G., The life skills profile: a measure assessing function and disability in schizophrenia. Schizophr Bull, 1989.
38. [38] Hajebi, A., Motevalian, A., Amin-Esmaeili, M., Hefazi, M., Radgoodarzi, R., Rahimi-Movaghar, A., et al. Telephone versus face-to-face administration of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, for diagnosis of psychotic disorders. Compr Psychiatry 53:5 (2012), 579–583.
39. [39] Cannon, T.D., Cadenhead, K., Cornblatt, B., Woods, S.W., Addington, J., Walker, E., et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 65:January (1) (2008), 28–37.
40. [40] Meyer, E.C., Carrión, R.E., Cornblatt, B.A., Addington, J., Cadenhead, K.S., Cannon, T.D., et al. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophr Bull 40:6 (2014), 1452–1461.
41. [41] Chan, R.C.K., Wang, Y., Wang, L., Chen, E.Y.H., Manschreck, T.C., Li, Z., et al. Neurological soft signs and their relationships to neurocognitive functions: a re-visit with the structural equation modeling design. PLoS ONE, 4(12), 2009, e8469.
42. [42] Hosmer, D.W. Jr., Lemeshow, S., Sturdivant, R.X., Applied logistic regression [Internet]. 2013, John Wiley & Sons, Inc., Hoboken, NJ, USA.
43. [43] Sauerbrei, W., Schumacher, M., A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med 11:16 (1992), 2093–2109.
44. [44] Lin, A., Yung, A.R., Nelson, B., Brewer, W.J., Riley, R., Simmons, M., et al. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis. Psychol Med 43:11 (2013), 2349–2360.
45. [45] Giuliano, A.J., Li, H., Mesholam-Gately, R.I., Sorenson, S.M., Woodberry, K.A., Seidman, L.J., Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr Pharm Des 18:4 (2012), 399–415.
46. [46] Ilonen, T., Heinimaa, M., Korkeila, J., Svirskis, T., Salokangas, R.K.R., Differentiating adolescents at clinical high risk for psychosis from psychotic and non-psychotic patients with the Rorschach. Psychiatry Res 179:2 (2010), 151–156.
47. [47] Lindgren, M., Manninen, M., Laajasalo, T., Mustonen, U., Kalska, H., Suvisaari, J., et al. The relationship between psychotic-like symptoms and neurocognitive performance in a general adolescent psychiatric sample. Schizophr Res 123:1 (2010), 77–85.
48. [48] Fusar-Poli, P., Deste, G., Smieskova, R., Barlati, S., Yung, A.R., Howes, O., et al. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry 69:6 (2012), 562–571.
49. [49] Kim, H.S., Shin, N.Y., Jang, J.H., Kim, E., Shim, G., Park, H.Y., et al. Social cognition and neurocognition as predictors of conversion to psychosis in individuals at ultra-high risk. Schizophr Res 130:August (1–3) (2011), 170–175.
50. [50] Van Overwalle, F., Baetens, K., Understanding others’ actions and goals by mirror and mentalizing systems: a meta-analysis. Neuroimage 48:3 (2009), 564–584.
51. [51] Zhao, Q., Li, Z., Huang, J., Yan, C., Dazzan, P., Pantelis, C., et al. Neurological soft signs are not “soft” in brain structure and functional networks: evidence from ALE meta-analysis. Schizophr Bull 40:May (3) (2014), 626–641.
52. [52] Tanaka, S., Modality-specific cognitive function of medial and lateral human Brodmann area 6. J Neurosci 25:2 (2005), 496–501.
53. [53] Herold, R., Feldmann, A., Simon, M., Tényi, T., Kövér, F., Nagy, F., et al. Regional gray matter reduction and theory of mind deficit in the early phase of schizophrenia: a voxel-based morphometric study. Acta Psychiatr Scand 119:3 (2009), 199–208.
54. [54] Corcoran, C.M., Keilp, J.G., Kayser, J., Klim, C., Butler, P.D., Bruder, G.E., et al. Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective. Psychol Med 45:14 (2015), 2959–2973.
55. [55] Cornblatt, B.A., Lencz, T., Smith, C.W., Olsen, R., Auther, A.M., Nakayama, E., et al. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry 68:4 (2007), 546–557.